Brandon Hogstad, PhD is an AI-implementation consultant who helps executives and product teams put generative AI to work. Drawing on a deep research and early-stage innovation background, Brandon excels at distilling complex science and technology into clear, practical tools and playbooks that drive immediate results. He specializes in strategic commercialization, partnerships, competitive intelligence, and scientific due diligence—bridging the gap between cutting-edge research and market-ready products. Previously, he built drug-discovery accelerator programs at NYU Langone Health, forging collaborations with Sanofi and Pfizer (contributing research that informed Paxlovid). He later led AI-driven immunotherapy initiatives at Immunai, harnessing machine learning and single-cell genomics for precision medicine. Brandon earned his PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai. Outside of consulting and coaching, he releases music with his brother as The Hogstad Brothers.

Return to Who we are